QuantCapitol. Congressional Trading Intelligence

Updated 2026-11-05 08:10 UTC · Public disclosure record

CRLTICKER

Charles River Laboratories International, Inc.

VERY BULLISH stock

Congress has disclosed 11 buys and 8 sells of CRL (Charles River Laboratories International, Inc.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.

Activity Congressional Activity

11
Buy
8
Sell
+3
Net
9
Active politicians

Round-trip watch Still on the books

Members who disclosed buying CRL and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.

MemberEntry (last buy)Entry priceNowvs entryStatus
Jefferson Shreve 2025-05-08 $141.36 $359.41 +154.3% in profit
Julie Johnson 2025-01-15 $173.91 $359.41 +106.7% in profit

Price as of 2026-10-30. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).

Price & congressional trades
Buy Sell

Fundamentals · FY2026 Valuation

Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for —. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.

P/E
428.53
no sector median
how it's calculated
P/E = price ÷ earnings per share
$359.41 ÷ $0.84 = 428.53
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
P/B
5.34
no sector median
how it's calculated
P/B = price ÷ book value per share
$359.41 ÷ $67.35 = 5.34
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
EV/EBITDA
30.28
no sector median
how it's calculated
EV/EBITDA = (market cap + net debt) ÷ EBITDA — net cash lowers EV
($17.2B − $0.2B net cash) ÷ $0.6B = $17.0B ÷ $0.6B = 30.28
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.

19 trades Recent Congressional Trades

Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.

PoliticianChamberTypeOwnerDateDisclosure lagPrice move
in that
window
AmountScoreSource
Rob Bresnahan House SELL ◆ insider convergence Self · JP Morgan Brokerage Account 2025-05-15 0 days 0.0% $1K–$15K
0.2% of NW
28.5 ↗ filing
Jefferson Shreve House BUY ◆ insider divergence Self · CRT - Standard Unit Trust 2025-05-08 7 days -1.7% $15K–$50K
<0.1% of NW
84.7 ↗ filing
Rob Bresnahan House BUY ◆ insider convergence · strong Self · JP Morgan Brokerage Account 2025-04-08 0 days 0.0% $15K–$50K
0.9% of NW
88.7 ↗ filing
Julie Johnson House BUY ◆ insider convergence · strong Joint · Merrill Lynch Tax Efficient Core 2025-01-15 23 days -5.8% $1K–$15K
<0.1% of NW
62.6 ↗ filing
Lois Frankel House SELL ◆ insider convergence · moderate Self · Morgan Stanley IRA - X142 2023-09-08 28 days — $1K–$15K
0.3% of NW
40.4 ↗ filing
Lois Frankel House BUY ◆ insider divergence Self · Morgan Stanley IRA - X142 2023-04-25 24 days — $1K–$15K
0.3% of NW
75.9 ↗ filing
Zoe Lofgren House SELL Spouse · John Marshall Collins Rollover IRA 2022-08-25 19 days — $1K–$15K
0.1% of NW
40.4 ↗ filing
Zoe Lofgren House BUY Spouse 2021-09-30 7 days — $1K–$15K
0.1% of NW
75.9 ↗ filing
Susie Lee House SELL Joint 2019-10-08 23 days — $1K–$15K
0.2% of NW
22.3 ↗ filing
Susie Lee House SELL Joint 2019-10-07 24 days — $1K–$15K
0.2% of NW
40.4 ↗ filing
Susie Lee House BUY Joint 2019-08-29 3 days — $1K–$15K
0.2% of NW
75.9 ↗ filing
Donna Shalala House SELL Self 2019-06-24 6 days — $1K–$15K 75.9 ↗ filing
Lamar Smith House SELL Self 2018-09-26 5 days — $1K–$15K 22.3 ↗ filing
Thomas MacArthur House BUY Joint 2018-09-19 12 days — $1K–$15K 15.7 ↗ filing
Thomas MacArthur House BUY Joint 2018-09-13 18 days — $1K–$15K 22.3 ↗ filing
Thomas MacArthur House BUY Joint 2018-09-12 19 days — $1K–$15K 40.4 ↗ filing
Thomas MacArthur House BUY Joint 2018-09-11 20 days — $1K–$15K 75.9 ↗ filing
Lamar Smith House SELL Self 2018-07-26 11 days — $1K–$15K 40.4 ↗ filing
Lamar Smith House BUY Self 2018-02-13 20 days — $1K–$15K 75.9 ↗ filing

Corporate insiders · SEC Form 4 Insider Activity

What the company's own officers and directors did in CRL — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →

4
Congress trades with insider convergence
2
…with insider divergence
101
Insider open-market trades

Of the congressional trades in CRL, 4 coincided with corporate insiders moving the same way within 60 days, and 2 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.

DateInsiderRoleTypeSizeSource
2026-10-22 FOSTER JAMES C Director SELL 10b5-1 $8.4M ↗ EDGAR
2026-10-21 Parisotto Shannon M Other SELL 10b5-1 $743K ↗ EDGAR
2026-10-05 Parisotto Shannon M Other SELL 10b5-1 $303K ↗ EDGAR
2026-09-30 Coleman Glenn C-suite BUY $3K ↗ EDGAR
2026-08-25 FOSTER JAMES C Director SELL 10b5-1 $10.1M ↗ EDGAR
2026-08-19 Parisotto Shannon M Other SELL 10b5-1 $600K ↗ EDGAR
2026-08-18 Andrews Nancy C Director SELL $163K ↗ EDGAR
2026-08-11 Parisotto Shannon M Other SELL 10b5-1 $1.0M ↗ EDGAR
2026-08-11 Girshick Birgit C-suite SELL 10b5-1 $1.8M ↗ EDGAR
2026-08-10 FOSTER JAMES C Director SELL 10b5-1 $7.9M ↗ EDGAR
2026-08-06 Creamer Victoria L C-suite SELL $1.1M ↗ EDGAR
2026-08-06 Knell Michael Gunnar Other SELL $330K ↗ EDGAR
2026-08-06 Knell Michael Gunnar Other SELL $235K ↗ EDGAR
2026-08-06 Knell Michael Gunnar Other SELL $212K ↗ EDGAR
2026-08-06 Knell Michael Gunnar Other SELL $56K ↗ EDGAR
2026-08-06 Knell Michael Gunnar Other SELL $164K ↗ EDGAR
2026-08-06 Knell Michael Gunnar Other SELL $128K ↗ EDGAR
2026-08-06 Knell Michael Gunnar Other SELL $104K ↗ EDGAR
2026-08-06 Knell Michael Gunnar Other SELL $312K ↗ EDGAR
2026-08-06 Knell Michael Gunnar Other SELL $190K ↗ EDGAR
2026-08-05 Parisotto Shannon M Other SELL 10b5-1 $1.3M ↗ EDGAR
2026-06-29 FOSTER JAMES C Director SELL 10b5-1 $16.9M ↗ EDGAR
2026-03-03 LaPlume Joseph W Other BUY $4K ↗ EDGAR
2025-08-22 LaPlume Joseph W Other SELL $65K ↗ EDGAR
2025-08-18 LaPlume Joseph W Other SELL $126K ↗ EDGAR

Combined timeline — Congress & insiders

Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.

DateWhoTypeSize
◆ insider 2026-10-22 FOSTER JAMES C Director 10b5-1 SELL $8.4M
◆ insider 2026-10-21 Parisotto Shannon M Other 10b5-1 SELL $743K
◆ insider 2026-10-05 Parisotto Shannon M Other 10b5-1 SELL $303K
◆ insider 2026-09-30 Coleman Glenn C-suite BUY $3K
◆ insider 2026-08-25 FOSTER JAMES C Director 10b5-1 SELL $10.1M
◆ insider 2026-08-19 Parisotto Shannon M Other 10b5-1 SELL $600K
◆ insider 2026-08-18 Andrews Nancy C Director SELL $163K
◆ insider 2026-08-11 Parisotto Shannon M Other 10b5-1 SELL $1.0M
◆ insider 2026-08-11 Girshick Birgit C-suite 10b5-1 SELL $1.8M
◆ insider 2026-08-10 FOSTER JAMES C Director 10b5-1 SELL $7.9M
◆ insider 2026-08-06 Creamer Victoria L C-suite SELL $1.1M
◆ insider 2026-08-06 Knell Michael Gunnar Other SELL $330K
◆ insider 2026-08-06 Knell Michael Gunnar Other SELL $235K
◆ insider 2026-08-06 Knell Michael Gunnar Other SELL $212K
◆ insider 2026-08-06 Knell Michael Gunnar Other SELL $56K
◆ insider 2026-08-06 Knell Michael Gunnar Other SELL $164K
◆ insider 2026-08-06 Knell Michael Gunnar Other SELL $128K
◆ insider 2026-08-06 Knell Michael Gunnar Other SELL $104K
◆ insider 2026-08-06 Knell Michael Gunnar Other SELL $312K
◆ insider 2026-08-06 Knell Michael Gunnar Other SELL $190K
◆ insider 2026-08-05 Parisotto Shannon M Other 10b5-1 SELL $1.3M
◆ insider 2026-06-29 FOSTER JAMES C Director 10b5-1 SELL $16.9M
◆ insider 2026-03-03 LaPlume Joseph W Other BUY $4K
◆ insider 2025-08-22 LaPlume Joseph W Other SELL $65K

FAQ Common questions

How much has Congress traded CRL?

11 disclosed buys and 8 sells of CRL (Charles River Laboratories International, Inc.) appear in official congressional financial disclosures.

Is it legal for members of Congress to trade CRL?

Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.

Where does this data come from?

Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.

About this data. Sourced from official House Clerk and Senate eFD financial disclosures (Senate via a maintained community mirror — see project documentation). Transaction amounts are reported as ranges, not exact figures. Interest scores, consensus labels, and backtested performance are proprietary analytical calculations based on public data and are not investment advice. Backtested performance is a hypothetical simulation, not actual portfolio performance.